stockrowCabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +79.4%
- Free cash flow
- −51.7%
- Total debt
- +10.8%
Quarter to September 2026, against a year earlier
Follow CBT
Alert me
Cabot Corporation (CBT) Shares outstanding
Cabot Corporation's shares outstanding at the end of fiscal 2025 was $54.2M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $51.9M. Over the past ten years it has ranged from $54.2M (fiscal 2025) to $63.4M (fiscal 2015) — the current reading is the lowest in ten years. Cabot Corporation ranks 33rd of 59 Specialty Chemicals companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $54.2M | (2.69%) |
| FY2024 | $55.7M | (1.42%) |
| FY2023 | $56.5M | (0.70%) |
| FY2022 | $56.9M | 0.18% |
| FY2021 | $56.8M | 0.35% |
| FY2020 | $56.6M | (3.74%) |
| FY2019 | $58.8M | (4.70%) |
| FY2018 | $61.7M | (1.59%) |
| FY2017 | $62.7M | (0.32%) |
| FY2016 | $62.9M | (0.79%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $51.9M | (0.19%) |
| Jun 2026 | $52.0M | (0.38%) |
| Mar 2026 | $52.2M | (1.32%) |
| Dec 2025 | $52.9M | (2.40%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| PRM Perimeter Solutions, SA compare | $175.0M |
| AVNT Avient Corporation compare | $92.4M |
| CLMT Calumet, Inc. compare | $87.6M |
| FUL H. B. Fuller Company compare | $54.9M |
| CBT Cabot Corporation | $51.9M |
| ASH Ashland Inc. compare | $46.0M |
| SXT Sensient Technologies Corporation compare | $42.8M |
| HWKN Hawkins, Inc. compare | $20.8M |
| WDFC WD-40 Company compare | $13.5M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on CBT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement